Laurel Oak Wealth Management »

Apellis Pharmaceuticals shares owned by Laurel Oak Wealth Management

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Laurel Oak Wealth Management from 13F filings

Historical chart of Laurel Oak Wealth Management investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Laurel Oak Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Laurel Oak Wealth Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $341k 8.5k 40.23

More positions owned by Laurel Oak Wealth Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Vanguard Index Fds Growth Etf (VUG)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Listed Fds Tr Swan Hedged Eqty (HEGD)
JPMorgan Chase & Co. (JPM)
Spdr Series Trust State Street Spd (SPYV)
Vanguard Specialized Funds Div App Etf (VIG)
Amplify Etf Tr Cwp Enhanced Div (DIVO)
Vanguard Whitehall Fds High Div Yld (VYM)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Vanguard World Inf Tech Etf (VGT)

View all positions for Laurel Oak Wealth Management

Top funds holding Apellis Pharmaceuticals

Wellington Management Company
venBio Select Advisor
Vanguard Group
Deep Track Capital
Rtw Investments
BlackRock
UBS Group
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Suvretta Capital Management
Polar Capital Holdings
Siren
OrbiMed Advisors
AQR Capital Management

View all funds holding Apellis Pharmaceuticals